Loading...
Medios AG
MEDOF•PNK
Healthcare
Medical - Distribution
$50.00
$0.00(0.00%)
Medios AG (MEDOF) Financial Performance & Income Statement Overview
Review Medios AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.51%
↑ 5.51%
Operating Income Growth
0.94%
↑ 0.94%
Net Income Growth
-33.29%
↓ 33.29%
Operating Cash Flow Growth
349.01%
↑ 349.01%
Operating Margin
1.96%
↑ 1.96%
Gross Margin
8.08%
↑ 8.08%
Net Profit Margin
0.78%
↑ 0.78%
ROE
2.93%
↑ 2.93%
ROIC
4.99%
↑ 4.99%
Medios AG (MEDOF) Income Statement & Financial Overview
Review Medios AG's (MEDOF) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $482.53M | $493.24M | $451.04M | $456.22M |
Cost of Revenue | $436.54M | $446.61M | $437.14M | $443.64M |
Gross Profit | $46.00M | $46.64M | $13.89M | $12.59M |
Gross Profit Ratio | $0.10 | $0.09 | $0.03 | $0.03 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $7.26M |
Operating Expenses | $36.65M | $36.95M | $7.80M | $6.06M |
Total Costs & Expenses | $473.18M | $483.55M | $444.94M | $449.69M |
Interest Income | $439000.00 | $79000.00 | $496000.00 | $36000.00 |
Interest Expense | $4.31M | $3.53M | $2.31M | $707000.00 |
Depreciation & Amortization | $9.54M | $9.81M | $6.74M | $5.20M |
EBITDA | $19.33M | $19.58M | $13.33M | $11.73M |
EBITDA Ratio | $0.04 | $0.04 | $0.03 | $0.03 |
Operating Income | $9.35M | $9.69M | $6.09M | $6.53M |
Operating Income Ratio | $0.02 | $0.02 | $0.01 | $0.01 |
Other Income/Expenses (Net) | -$3.87M | -$3.46M | -$1.82M | -$671000.00 |
Income Before Tax | $5.48M | $6.24M | $4.28M | $5.86M |
Income Before Tax Ratio | $0.01 | $0.01 | $0.009 | $0.01 |
Income Tax Expense | $3.37M | $2.21M | $1.86M | $1.87M |
Net Income | $2.11M | $4.03M | $2.42M | $3.99M |
Net Income Ratio | $0.004 | $0.008 | $0.005 | $0.009 |
EPS | $0.09 | $0.00 | $0.10 | $0.17 |
Diluted EPS | $0.09 | $0.00 | $0.10 | $0.17 |
Weighted Avg Shares Outstanding | $25.51M | $0.00 | $24.43M | $23.81M |
Weighted Avg Shares Outstanding (Diluted) | $25.51M | $0.00 | $24.43M | $23.81M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan